Copyright
©The Author(s) 2021.
World J Gastroenterol. Apr 14, 2021; 27(14): 1362-1368
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1362
Published online Apr 14, 2021. doi: 10.3748/wjg.v27.i14.1362
Figure 1 Metformin mode of action including chemopreventive potential in colorectal cancer development.
CRC: Colorectal cancer; NF-kB: Nuclear factor kB; AMPK: Adenosine monophosphate-activated protein kinase; GSK3β: Glycogen synthase kinase-3β; PPAR-γ: Proliferator-activated receptor-γ; mTOR: Mechanistic target of rapamycin.
- Citation: Berkovic MC, Mikulic D, Bilic-Curcic I, Mrzljak A. How far along are we in revealing the connection between metformin and colorectal cancer? World J Gastroenterol 2021; 27(14): 1362-1368
- URL: https://www.wjgnet.com/1007-9327/full/v27/i14/1362.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i14.1362